Beijing Kawin Technology Share-Holding Co., Ltd. research, development, production and sales of drugs in the field of viral diseases. Its products include compound glycyrrhizin capsules, vaginal effervescent tablets, omeprazole sodium for injection, liraglutide, nivolumab, and filgrastim. The company was founded on August 20, 2008 and is headquartered in Beijing, China.